American Medical AssociationCOVID-19 Therapeutics for Non-Hospitalized Patients

Although there now exist many safe and approved therapeutics for non-hospitalized patients who have COVID-19 or one of its variants, these therapies are often distributed in an ineffective and unequitable manner, according to an article published by JAMA Network. The article highlights many of the available therapies and how to distribute them fairly to patients […]

MedPage TodayA COVID ‘Breathalyzer’: Not All Hot Air?

Since the onset of COVID-19, medical professionals have struggled to rapidly diagnose and determine whether someone has the respiratory illness. This issue is particularly acute in hospital intensive care units (ICUs) where doctors and nurses must triage patients based on the severity of their illnesses. Now, a “breathalyzer” test given to critically ill patients has […]

Everyday HealthTwo Doses of mRNA COVID Vax Not Enough for the Immunosuppressed

A study published in Morbidity & Mortality Weekly Report (MMWR) argues that immunosuppressed patients and people with compromised immune systems need more than two vaccine doses to achieve adequate protection against COVID-19. After two vaccine doses, immunocompromised patients saw 77% vaccine effectiveness against hospitalization, versus 90% for immunocompetent individuals.

The BMJEffectiveness of Public Health Measures in Reducing the Incidence of COVID-19, SARS-CoV-2 Transmission, and COVID-19 Mortality

Only 8 of 35 studies could be included in the meta-analysis. Combined, these indicate a 25% risk reduction for physical distancing, 53% for mask-wearing, and 53% for hand washing. The accompanying BMJ editorial explores the possible reasons for the findings and the oddity that so little quality research is available on such an important topic.